Expanded Use of TIMI Risk Score for CV Event Prediction in Diabetes
The TIMI Risk Score provides a practical risk assessment tool for patients with type 2 diabetes.
To understand the mechanism underlying the benefit of fenofibrate on vascular complications in patients with type 2 diabetes, investigators assessed carotid intima thickness as a marker of subclinical atherosclerosis.
Longer sleep duration and greater sleep efficiency linked to better metabolic risk scores in adolescents.
Investigators sought to determine whether methylglyoxal levels are associated with cardiovascular disease in type 2 diabetes.